Location Preston, Lancashire, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Dr Marcus has more than 20 years' pharmaceutical clinical development experience. Prior to joining Spinifex, Dr Marcus had a successful career at Bristol-Myers Squibb (BMS), having held a number of senior leadership positions within BMS' Neuroscience division.
Dr Marcus was most recently Executive Director, Neuroscience Global Clinical
Research at BMS. In this role he was Early Development team Leader for neuropathic pain, schizophrenia and migraine compounds and Life-Cycle Management (LCM) Team Leader for Ablify. He possesses both breadth and depth in all of the key functional areas of exploratory and late development, neauroscience and pain disease biology, and regulatory affairs.
Dr Marcus has been recognised within industry for his excellence in overall drug development, innovative strategic leadership and executional excellence while spearheading an industry leading life cycle management program for Ablify. In addition to the approval of over 20 NDAs and sNDAs globally for Ablify, Dr Marcus also led the successful development of Serzone, an antidepressant.
Dr Marcus received a BA in Psychology from University of Virginia. he earned his medical degree from SUNY Buffalo and completed his Psychiatry residency and NIMH research fellowship at Cornell University, New York Hospital-Westchester division. He has authored more than 80 peer-reviewed publications.
